loobobilly News: High Prices For Orphan Drugs Strain Families And Insurers

High Prices For Orphan Drugs Strain Families And Insurers Three decades ago, Congress set up a system to encourage drug companies to develop treatments for rare diseases. The law has worked but at a high cost. Three decades ago, Congress set up a system to encourage drug companies to develop treatments for rare diseases. The law has worked but at a high cost. Business
Three decades ago, Congress set up a system to encourage drug companies to develop treatments for rare diseases. The law has worked but at a high cost.

Read more on NPR